Your browser doesn't support javascript.
loading
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210).
Ferreras, Cristina; Hernández-Blanco, Clara; Martín-Quirós, Alejandro; Al-Akioui-Sanz, Karima; Mora-Rillo, Marta; Ibáñez, Fátima; Díaz-Almirón, Mariana; Cano-Ochando, Jordi; Lozano-Ojalvo, Daniel; Jiménez-González, María; Goterris, Rosa; Sánchez-Zapardiel, Elena; de Paz, Raquel; Guerra-García, Pilar; Queiruga-Parada, Javier; Molina, Pablo; Briones, María Luisa; Ruz-Caracuel, Beatriz; Borobia, Alberto M; Carcas, Antonio J; Planelles, Dolores; Vicario, José Luis; Moreno, Miguel Ángel; Balas, Antonio; Llano, Marta; Llorente, Andrea; Del Balzo, Álvaro; Cañada, Carlos; García, Miguel Ángel; Calvin, María Elena; Arenas, Isabel; Pérez de Diego, Rebeca; Eguizábal, Cristina; Soria, Bernat; Solano, Carlos; Pérez-Martínez, Antonio.
Affiliation
  • Ferreras C; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain.
  • Hernández-Blanco C; Internal Medicine Department, Hospital de Emergencias Enfermera Isabel Zendal, Madrid, Spain.
  • Martín-Quirós A; Emergency Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain.
  • Al-Akioui-Sanz K; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain.
  • Mora-Rillo M; Infectious Diseases Unit, Internal Medicine Department, University Hospital La Paz, Hospital La Paz Institute for Health Research, IdiPAZ, Consorcio Centro de Investigación Biomédica en Red CIBER-Infec, Madrid, Spain.
  • Ibáñez F; Internal Medicine Department, Hospital Puerta de Hierro, Madrid, Spain.
  • Díaz-Almirón M; Biostatistics Department, La Paz University Hospital, Madrid, Spain.
  • Cano-Ochando J; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Centro Nacional de Microbiologia, Instituto de Salud Carlos III, 28220 Madrid, Spain; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Lozano-Ojalvo D; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Jiménez-González M; Infectious Diseases Unit, Internal Medicine Department, University Hospital La Paz, Hospital La Paz Institute for Health Research, IdiPAZ, Consorcio Centro de Investigación Biomédica en Red CIBER-Infec, Madrid, Spain; Clinical Trials Unit (UCICEC) at Hospital La Paz Institute for Health Research, Id
  • Goterris R; Hematology Department, Hospital Clinico Universitario, Valencia, Spain.
  • Sánchez-Zapardiel E; Immunology Department, University Hospital La Paz, Madrid, Spain.
  • de Paz R; Hematology Department, University Hospital La Paz, Madrid, Spain.
  • Guerra-García P; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain; Pediatric Hemato-Oncology Department, University Hospital La Paz, Madrid, Spain.
  • Queiruga-Parada J; Clinical Pharmacology Department, University Hospital La Paz, Madrid, Spain.
  • Molina P; Clinical Pharmacology Department, University Hospital La Paz, Madrid, Spain.
  • Briones ML; Neumology Department, Hospital Clinico Universitario, Valencia, Spain.
  • Ruz-Caracuel B; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain.
  • Borobia AM; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain; Clinical Trials Unit (UCICEC) at Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain; Clinical Pharmacology Department, University Hospital La Paz, Madrid, S
  • Carcas AJ; Clinical Trials Unit (UCICEC) at Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain; Clinical Pharmacology Department, University Hospital La Paz, Madrid, Spain; Faculty of Medicine Universidad Autónoma de Madrid, Madrid, Spain.
  • Planelles D; Department of Histocompatibility, Centro de Transfusión de la Comunidad Valenciana, Valencia, Spain.
  • Vicario JL; Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.
  • Moreno MÁ; Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.
  • Balas A; Histocompatibility, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.
  • Llano M; Infectious Diseases Department, Hospital de Emergencias Enfermera Isabel Zendal, Madrid, Spain.
  • Llorente A; Infectious Diseases Department, Hospital de Emergencias Enfermera Isabel Zendal, Madrid, Spain.
  • Del Balzo Á; Emergency Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain.
  • Cañada C; Emergency Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain.
  • García MÁ; Emergency Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain.
  • Calvin ME; Emergency Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain.
  • Arenas I; Emergency Unit, Internal Medicine Department, University Hospital La Paz, Madrid, Spain.
  • Pérez de Diego R; Laboratory of Immunogenetics of Human Diseases, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain; Innate Immunity Group, IdiPAZ Institute for Health Research, La Paz University Hospital, Madrid, Spain; Interdepartmental Group of Immunodeficiencies, Madrid, Spain.
  • Eguizábal C; Research Unit, Basque Centre for Blood Transfusion and Human Tissues, Osakidetza, Bizkaia, Spain; Biocruces Bizkaia Health Research Institute, Bizkaia, Spain.
  • Soria B; Health Research Institute-ISABIAL, Alicante University Hospital and Institute of Bioengineering, Miguel Hernández University, Alicante, Spain; University Pablo de Olavide, Sevilla, Spain.
  • Solano C; Hematology Department, Hospital Clinico Universitario, Valencia, Spain; Department of Medicine, University of Valencia, Valencia, Spain.
  • Pérez-Martínez A; Hospital La Paz Institute for Health Research, IdiPAZ, University Hospital La Paz, Madrid, Spain; Pediatric Hemato-Oncology Department, University Hospital La Paz, Madrid, Spain; Faculty of Medicine Universidad Autónoma de Madrid, Madrid, Spain. Electronic address: aperezmartinez@salud.madrid.org.
Cytotherapy ; 26(1): 25-35, 2024 Jan.
Article de En | MEDLINE | ID: mdl-37897472
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 / Lymphopénie Limites: Humans Langue: En Journal: Cytotherapy Sujet du journal: TERAPEUTICA Année: 2024 Type de document: Article Pays d'affiliation: Espagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 / Lymphopénie Limites: Humans Langue: En Journal: Cytotherapy Sujet du journal: TERAPEUTICA Année: 2024 Type de document: Article Pays d'affiliation: Espagne